 Clover Health NASDAQ: CLOV is losing its sponsor and must fly on alone. Chamath Palihapitiya, the SPAC King who brought CLOV stock public in early 2021 at about 16 per share its now at 1.86, has cut his stake in the Medicare Advantage provider to less than 5. 